Celgene wasn’t singled out by name in a speech by HHS Secretary Alex Azar Monday, but the big biotech got cast in the role of main villain in his outline of what ails Medicare — and how that should be fixed.
Trending:
HHS Secretary Azar pitches naming and shaming tactics on drug price campaign, singling out Celgene's Revlimid